3 results match your criteria: "Clinical Center of the Sarajevo University[Affiliation]"
Med Arh
February 2012
Institute for Clinical Immunology, Clinical Center of the Sarajevo University, Sarajevo, Bosnia and Herzegovina.
Introduction: In this study the authors have analyzed the costs associated with the immunosuppressive therapy in patients who underwent organ transplantation in two countries: the United States of America and Bosnia and Herzegovina (i.e. the entity Federation B&H).
View Article and Find Full Text PDFNeuroendocrinology
March 2010
Institute of Nuclear Medicine, Clinical Center of the Sarajevo University, Sarajevo, Bosnia and Herzegovina.
Aim: The aim of the study was to evaluate the current role of (123)I-MIBG scintigraphy in the detection and follow-up of patients with paragangliomas.
Materials And Methods: 117 patients were referred for diagnostic (123)I-MIBG scintigraphy based on a strong clinical suspicion, positive familial history and genetic testing, or for follow-up of paragangliomas.(123)I-MIBG images were analyzed and correlated with (111)In-octreotide scintigraphy, CT or MRI results.
Clin Nucl Med
April 2006
Clinical Center of the Sarajevo University, Sarajevo, Bosnia and Herzegovina.
Sentinel node imaging and biopsy have become standard procedures for staging early breast cancer. Positive sentinel lymph node (SLN) biopsy necessitates the need for axillary lymph node dissection (ALND). Failure to visualize a sentinel lymph node in recurrent breast cancer after treatment by surgery, chemotherapy, and high-dose postoperative radiation therapy is almost the case in every patient.
View Article and Find Full Text PDF